when to switch from semaglutide to tirzepatide Switching dose conversion Switching from Semaglutide to Tirzepatide:

And patients with a BMI of 27 or higher may qualify if they have pre-diabetes or a history of heart attack, stroke or peripheral artery disease

CagriSema is Novo Nordisks newest weight loss injection, a first-in-class combination of two drugs in one weekly shot: semaglutide 2.4 mg and cagrilintide 2.4 mg

PlexusDx providers can offer personalized nutrition guidance, especially when paired with the Precision Peptide Genetic Test, which reveals your individual metabolic tendencies

Why clean matters for a dosing protocol The selectivity is not just a talking point it shapes how the compound is dosed

Tirzepatide Tirzepatide is a dual agonist, meaning it acts as both a GLP-1 and GIP receptor agonist

2000, 72 (2): 618s-623s